chr16-1220162-G-A
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_021098.3(CACNA1H):c.6230G>A(p.Arg2077His) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.608 in 1,523,120 control chromosomes in the GnomAD database, including 285,545 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/19 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Consequence
NM_021098.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -20 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CACNA1H | NM_021098.3 | c.6230G>A | p.Arg2077His | missense_variant | 35/35 | ENST00000348261.11 | NP_066921.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CACNA1H | ENST00000348261.11 | c.6230G>A | p.Arg2077His | missense_variant | 35/35 | 1 | NM_021098.3 | ENSP00000334198.7 | ||
CACNA1H | ENST00000565831.6 | c.6212G>A | p.Arg2071His | missense_variant | 33/33 | 1 | ENSP00000455840.1 | |||
CACNA1H | ENST00000638323.1 | c.6191G>A | p.Arg2064His | missense_variant | 35/35 | 5 | ENSP00000492267.1 | |||
CACNA1H | ENST00000569107.5 | c.2468G>A | p.Arg823His | missense_variant | 17/17 | 1 | ENSP00000454990.2 | |||
CACNA1H | ENST00000564231.5 | c.2420G>A | p.Arg807His | missense_variant | 18/18 | 1 | ENSP00000457555.2 | |||
CACNA1H | ENST00000562079.5 | c.2402G>A | p.Arg801His | missense_variant | 17/17 | 1 | ENSP00000454581.2 | |||
CACNA1H | ENST00000639478.1 | n.*1278G>A | non_coding_transcript_exon_variant | 35/35 | 5 | ENSP00000491945.1 | ||||
CACNA1H | ENST00000640028.1 | n.*4048G>A | non_coding_transcript_exon_variant | 35/35 | 5 | ENSP00000491488.1 | ||||
CACNA1H | ENST00000639478.1 | n.*1278G>A | 3_prime_UTR_variant | 35/35 | 5 | ENSP00000491945.1 | ||||
CACNA1H | ENST00000640028.1 | n.*4048G>A | 3_prime_UTR_variant | 35/35 | 5 | ENSP00000491488.1 |
Frequencies
GnomAD3 genomes AF: 0.650 AC: 98790AN: 152052Hom.: 32623 Cov.: 35
GnomAD3 exomes AF: 0.657 AC: 109910AN: 167372Hom.: 36649 AF XY: 0.646 AC XY: 59692AN XY: 92374
GnomAD4 exome AF: 0.604 AC: 827558AN: 1370950Hom.: 252894 Cov.: 70 AF XY: 0.602 AC XY: 405972AN XY: 674462
GnomAD4 genome AF: 0.650 AC: 98862AN: 152170Hom.: 32651 Cov.: 35 AF XY: 0.657 AC XY: 48845AN XY: 74366
ClinVar
Submissions by phenotype
not provided Benign:3
Benign, criteria provided, single submitter | clinical testing | Athena Diagnostics | Apr 20, 2017 | - - |
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Benign, criteria provided, single submitter | clinical testing | GeneDx | Nov 27, 2019 | - - |
Epilepsy, childhood absence, susceptibility to, 6 Benign:2
Benign, no assertion criteria provided | clinical testing | Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen | - | - - |
Benign, criteria provided, single submitter | clinical testing | Genome Diagnostics Laboratory, University Medical Center Utrecht | Jul 28, 2017 | - - |
not specified Benign:1
Benign, criteria provided, single submitter | clinical testing | Eurofins Ntd Llc (ga) | Jul 03, 2013 | - - |
Idiopathic generalized epilepsy;C4310756:Hyperaldosteronism, familial, type IV Benign:1
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Feb 01, 2024 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at